,i #aahth ,,congress #ast ,session ,h4 ,r4 #fdbd ,,in ,,the ,,house ,,of ,,representatives ,november #ae1 #bjbc,mr4 ,fitzpatrick 7for himself1 ,ms4 ,houlahan1 and ,ms4 ,salazar7 introduced the following bill2 which was referred to the ,committee on ,foreign ,affairs ,a ,,bill ,to provide additional authorities for the leadership of the ,united ,states ,agency for ,international ,development in health technology innovation for global health in low-resource settings1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,supporting ,innovative ,global ,health ,technologies ,act of #bjbc or the ,,sight ,act4 #b4 ,findings ,congress finds the following3 7#a7 ,the ,united ,states ,agency for ,international ,development has a unique role in the research and development of health technologies for global health that complements the work of other departments and agencies of the ,united ,states ,government1 having both an advantage and unique mandate for development of health technologies for use in low-resource settings4 7#b7 ,it is in the national interest of the ,united ,states to build greater country capacity for research and development of new health technologies in low and middle-income countries4 7#c7 ,investments by the ,united ,states ,government in global health research and development should be coordinated with and leverage investments from partner country governments1 other government donors1 and the private sector4 7#d7 ,human immunodeficiency virus1 tuberculosis1 malaria1 neglected tropical diseases1 emerging infectious diseases 7such as ,,covid-#ai1 ,ebola1 and ,zika71 and many other health conditions 7such as complications in pregnancy7 have a disproportionate public health burden in low- and middle-income countries4 7#e7 ,health technologies that were developed for use in high-income countries often cannot be implemented in low-resource settings in low- and middle-income countries or require adaptation to be effective4 7#f7 ,due to poverty or to low incidence1 many neglected tropical diseases and emerging infectious diseases either lack or have limited commercial markets to drive health technology innovation4 7#g7 ,achieving the ambitious goals set through initiatives such as the ,president's ,emergency ,plan for ,,aids ,relief 7commonly referred to as ,,pepfar7 and the ,president's ,malaria ,initiative 7commonly referred to as ,,pmi7 will not be possible without the development and scale-up of new health technologies designed for use in low-resource settings1 which are needed to address both long-standing endemic diseases and prepare for potential pandemic threats4 7#h7 ,public funding has proven highly successful at incentivizing the development of health technologies for global health that are high-impact1 accessible1 and cost-saving4 7#i7 ,,covid-#ai has demonstrated the importance of global access to health technologies designed for low-resource settings4 7#aj7 ,support for the development of accessible health technologies for low-resource settings can have reciprocal value and produce tools that reduce health care costs1 improve public health1 and strengthen health security for the ,united ,states4 7#aa7 ,for decades1 the ,united ,states ,agency for ,international ,development has been a catalyst in the global health innovation ecosystem4 ,while other ,federal departments and agencies1 including the ,national ,institutes of ,health1 the ,centers for ,disease ,control and ,prevention1 and the ,department of ,defense1 provide support for global health technologies1 the ,united ,states ,agency for ,international ,development is the only ,federal agency that provides broad support for the late-stage development of new health technologies to combat neglected tropical diseases and emerging infectious diseases and other health conditions for low-resource settings specifically4 7#ab7 ,while the need for new tools to tackle disease threats has grown1 in recent years1 investments by the ,united ,states ,agency for ,international ,development in research and development have shrunk as a proportion of its overall global health spending1 squeezed by both stagnant budgets and growing needs4 7#ac7 ,innovation at the ,united ,states ,agency for ,international ,development is primarily supported from siloed disease- and population-specific appropriations accounts1 resulting in the limitation of its ability to seek shared value across health sectors or health threats4 7#ad7 ,the ,united ,states ,agency for ,international ,development is compelled to prioritize support for immediate program needs with imperfect tools at the expense of support for technologies that can improve clinical effectiveness1 increase access to care1 save costs1 and build capacity and ownership by partner countries4 #c4 ,statement of policy ,it is the policy of the ,united ,states that-- 7#a7 research and development for new health technologies is essential for the success of the global health programs of the ,united ,states ,government1 by providing for the improved effectiveness1 cost-effectiveness1 and sustainability of such programs2 and 7#b7 funding and other support for global health research and development under this ,act shall be additional and complementary to1 and may not replace1 displace1 or otherwise compromise1 funding otherwise provided for existing and ongoing global health research and development of the ,united ,states ,government or activities relating to the implementation of the global health programs of the ,united ,states ,government4 #d4 ,chief ,innovation ,officer for ,health 7a7 ,establishment ,there is established within the ,bureau for ,global ,health of the ,agency the position of ,chief ,innovation ,officer for ,health4 ,such position is at the level of ,deputy ,assistant ,administrator or equivalent4 7b7 ,appointment ,the ,administrator shall appoint the ,chief ,innovation ,officer for ,health from among such individuals as the ,administrator determines have relevant experience within private sector industry and an expert understanding of health finance and of the research1 development1 testing1 evaluation1 deployment1 and implementation of new health technology4 7c7 ,relationship to ,assistant ,administrator for ,global ,health ,the ,chief ,innovation ,officer for ,health shall-- 7#a7 serve as the principal advisor to the ,assistant ,administrator for ,global ,health on global health research and development necessary to meet the requirements of the ,united ,states ,government and the governments of partner countries for improving global health2 and 7#b7 report directly to the ,assistant ,administrator for ,global ,health4 7d7 ,duties ,the ,chief ,innovation ,officer for ,health shall be responsible for the following3 7#a7 ,ensuring cross-sector1 ,agency-wide cooperation1 support1 and programming for global health research and development1 for the purpose of increasing the effectiveness of international development programs of the ,agency and supporting the foreign policy and development goals of the ,united ,states ,government4 7#b7 ,drawing on the expertise of other departments and agencies of the ,united ,states ,government and of nongovernmental organizations 7including affected communities and institutions in low- or middle-income countries1 businesses1 health and science research organizations1 and institutions of higher education7 that pursue global health-related research and development1 to identify the most pressing requirements for the development of health technologies to improve global health and programs of the ,agency relating to global health4 7#c7 ,leveraging research and investments by other elements of the ,agency1 other departments and agencies of the ,united ,states ,government1 and nongovernmental organizations 7including businesses1 health and science research organizations1 institutions of higher education1 and governments or other institutions of partner countries7 to support the research and development of new health technologies by the ,chief ,innovation ,officer of ,health4 7#d7 ,administering the processes for the award of grants1 entry into partnerships1 and joint establishment of other arrangements1 to support global health research and development 7including by administering the grant program under section #g74 7#e7 ,serving as the ,chairperson of the ,global ,health ,research and ,development ,advisory ,council established under section #e4 7e7 ,authorities ,the ,assistant ,administrator for ,global ,health shall take such steps as may be necessary to ensure that the ,chief ,innovation ,officer for ,health has sufficient authority within the ,bureau for ,global ,health to carry out the duties under subsection 7d74 #e4 ,global ,health ,research and ,development ,advisory ,council 7a7 ,establishment ,the ,administrator shall establish an advisory council to be known as the ,global ,health ,research and ,development ,advisory ,council 7in this section referred to as the ,council74 7b7 ,membership ,the ,council shall be composed of the following3 7#a7 ,the ,chief ,innovation ,officer for ,health of the ,agency under section #d1 who shall serve as the ,chairperson of the ,council 7in this section referred to as the ,chairperson74 7#b7 ,not more than #h other members appointed by the ,administrator from among individuals-- 7,a7 recommended for such appointment by the ,chairperson2 and 7,b7 who are scientists or other experts with experience in global health research and development through or on behalf of-- 7i7 the ,agency2 7ii7 any other department or agency of the ,united ,states ,government2 7iii7 affected communities in low- or middle-income countries2 and 7iv7 nongovernmental organizations1 including nonprofit organizations1 businesses1 and institutes of higher education4 7c7 ,terms 7#a7 ,in general ,each member other than the ,chairperson shall be appointed for a term of #f years4 7#b7 ,vacancies ,any member appointed to fill a vacancy occurring before the expiration of the term for which the predecessor of the member was appointed shall be appointed only for the remainder of that term4 ,a vacancy in the ,council shall be filled in the manner in which the original appointment was made4 7d7 ,compensation 7#a7 ,prohibition of compensation of ,federal employees ,except as provided in paragraph 7#b71 members of the ,council who are full-time officers or employees of the ,united ,states may not receive additional pay1 allowances1 or benefits by reason of their service on the ,council4 7#b7 ,travel expenses ,each member of the ,council shall receive travel expenses1 including per diem in lieu of subsistence1 in accordance with applicable provisions under subchapter ,i of chapter #eg of title #e1 ,united ,states ,code4 7e7 ,meetings ,the ,council shall meet at the call of the ,chairperson4 7f7 ,duties ,the ,council shall be responsible for advising the ,administrator regarding the priorities and objectives for the ,agency with respect to global health research and development1 including by providing such advice on an individual member basis or as a collective ,council1 as the ,chairperson may direct4 7g7 ,nonapplicability of ,federal ,advisory ,committee ,act ,chapter #aj of title #e1 ,united ,states ,code1 shall not apply to the ,council4 #f4 ,global ,health ,research and ,development program area activities and budget 7a7 ,in general ,the ,administrator shall carry out global health research and development activities with respect to new health technologies with the potential to advance the effectiveness and sustainability of the global health programs of the ,agency1 including the potential to advance-- 7#a7 health technologies with characteristics identified or otherwise prioritized by affected communities and partner countries2 7#b7 health technologies with characteristics that facilitate introduction and access of the respective technology1 to ensure use by those in need2 and 7#c7 support for capacity-building within partner countries and the transition by such countries to greater country-level ownership1 responsibility1 and decision-making with respect to global health4 7b7 ,budget ,the ,administrator shall-- 7#a7 not later than #ij days after the date of the enactment of this ,act1 establish a single1 separate budget line for the activities under subsection 7a71 under which funds authorized to be appropriated or otherwise made available to the ,administrator for the purpose of carrying out such activities shall be categorized2 and 7#b7 include information regarding amounts expended and requested to be expended under such budget line in the budget justification materials submitted in support of the budget of the ,president for any fiscal year beginning on or after the date of such establishment4 #g4 ,grant program for expanded use of global health research and development 7a7 ,grant program ,the ,administrator1 acting through the ,chief ,innovation ,officer for ,health under section #d1 shall carry out a grant program under which the ,administrator may award grants on a competitive basis to nongovernmental organizations that are determined eligible by the ,administrator4 7b7 ,use of amounts ,grant amounts awarded under this section may only be used for the following purposes3 7#a7 ,developing new health technologies designed for use in low-resource settings to improve global health4 7#b7 ,evaluating and improving the implementation1 production1 and scale-up of health technologies in low-resource settings in partner countries4 7#c7 ,investing in the research capacity of institutions in low- and middle-income partner countries to lead and contribute to the development of health technologies4 7c7 ,conditions on grant award ,the ,administrator may not award a grant to an entity under this section unless-- 7#a7 the entity submits to the ,administrator a proposal demonstrating sufficient technical standards1 as determined by the ,administrator1 for any of the purposes listed in paragraphs 7#a7 through 7#c7 of subsection 7b7 for which the entity intends to use such grant amounts2 7#b7 the entity agrees1 as a condition of such award1 to report to the ,administrator regarding the use of such grant amounts on a basis that is not less frequent than annually for the duration of the grant period2 and 7#c7 the ,administrator certifies to the appropriate congressional committees that such award is in compliance with section #c7b7 of this ,act4 7d7 ,additional nature of authority ,the authority to award grants under this section is in addition to1 and not in lieu of1 any other authority of the ,administrator1 including any such authority under part ,i or ,,ii of the ,foreign ,assistance ,act of #aifa 7#bb ,u4,s4,c4 #baea et seq474 #h4 ,strategy and reports 7a7 ,report on progress ,not later than #ahj days after the date of the enactment of this ,act1 and prior to the submission of the budget justification materials in support of the budget of the ,president for the first fiscal year following the date of the enactment of this ,act1 the ,administrator shall submit to the appropriate congressional committees1 and publish on a publicly available website of the ,agency1 a report that contains the following3 7#a7 ,a detailed description of the status of the ,global ,health ,research and ,development ,advisory ,council under section #e4 7#b7 ,recommendations by such ,global ,health ,research and ,development ,advisory ,council4 7#c7 ,solicitations for grant awards under section #g4 7#d7 ,comprehensive accounting of awards and objectives to be included within the annual report to ,congress on the health-related research and development strategy of the ,agency required pursuant to the ,department of ,state1 ,foreign ,operations1 and ,related ,programs ,appropriations ,act 7or the report accompanying such appropriations bill reported by the ,committees on ,appropriations of the ,house or ,representatives or ,senate7 for the respective fiscal year4 7#e7 ,a detailed description of how the planned investments by the ,agency in the activities under section #f7;a7 align with the multiyear strategy of the ,agency titled ,global ,health ,research and ,development ,strategy #bjbc-bjbh and developed pursuant to section #gjai7;e7 of division ,k of the ,consolidated ,appropriations ,act1 #bjbb 7,public ,law #aag-ajc74 7#f7 ,a detailed description of how investments made by the ,agency in such activities advance the other health-related programming goals of the ,agency4 7b7 ,annual reports ,not later than #a year after the date of the enactment of this ,act1 and annually thereafter for the next #e years as part of the annual report specified in subsection 7a77#d71 the ,administrator shall submit to the appropriate congressional committees1 and publish on a publicly available website of the ,agency1 a report that contains1 with respect to the year covered by the report1 the following3 7#a7 ,information on any grants awarded1 or other assistance provided1 by the ,administrator during such year pursuant to an authority under this ,act or any other relevant provision of law for the support of global health research and development in support of programs of the ,agency4 7#b7 ,the primary1 secondary1 and tertiary purposes of-- 7,a7 any such grants awarded2 and 7,b7 any investments in the activities under section #f7;a7 made or proposed by the ,administrator during such year4 7#c7 ,a summary of how affected communities and researchers based in partner countries have been consulted with respect to any such investments4 7#d7 ,a description of the outcomes and status of the activities under section #f7;a7 carried out or otherwise supported by the ,administrator during such year4 7#e7 ,an identification of any amounts obligated or expended during such year by the ,administrator1 from any appropriations account1 to support global health research and development4 ,such information shall be presented both as a summary and in a table delineated by-- 7,a7 health area2 7,b7 type of research or development activity2 and 7,c7 appropriations account4 7#f7 ,a description of relevant objectives and expected outcomes for the subsequent year4 #i4 ,definitions ,in this ,act3 7#a7 ,administrator ,the term ,administrator means the ,administrator for the ,united ,states ,agency for ,international ,development4 7#b7 ,agency ,the term ,agency means the ,united ,states ,agency for ,international ,development4 7#c7 ,appropriate congressional committees ,the term appropriate congressional committees means-- 7,a7 the ,committee on ,foreign ,affairs of the ,house of ,representatives2 and 7,b7 the ,committee on ,foreign ,relations of the ,senate4 7#d7 ,global health ,the term global health includes efforts to combat and prepare for-- 7,a7 neglected tropical diseases2 7,b7 emerging infectious diseases2 7,c7 antimicrobial resistance2 and 7,d7 any other condition that may not be easily treated1 diagnosed1 or prevented in low-resource settings4 7#e7 ,global health research and development ,the term global health research and development includes an activity1 or the support for such an activity1 related to research1 development1 testing1 evaluation1 deployment1 or implementation of any new health technology4 7#f7 ,health technology ,the term health technology-- 7,a7 means a vaccine1 therapeutic1 diagnostic1 device1 or other tool designed1 modified1 or adapted for use in low-resource settings to improve global health2 and 7,b7 includes personal protective equipment and insecticide so used4 7#g7 ,low-resource setting ,the term low-resource setting means a location with limited or inconsistent access to running water1 electricity1 refrigeration1 supply chains1 lab services1 medical equipment1 trained health care personnel1 or other resources important for global health4